Cytimmune Sciences Revenue and Competitors
Estimated Revenue & Valuation
- Cytimmune Sciences's estimated annual revenue is currently $1.4M per year.
- Cytimmune Sciences's estimated revenue per employee is $155,000
Employee Data
- Cytimmune Sciences has 9 Employees.
- Cytimmune Sciences grew their employee count by 0% last year.
Cytimmune Sciences's People
| Name | Title | Email/Phone |
|---|
Cytimmune Sciences Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.3M | 2 | -60% | N/A | N/A |
#2 | $2.9M | 38 | -31% | $17.5M | N/A |
#3 | $2.9M | 38 | -33% | $10.5M | N/A |
#4 | $19.8M | 128 | 0% | $69.4M | N/A |
#5 | $9.6M | 62 | -15% | N/A | N/A |
#6 | $1.4M | 9 | 0% | N/A | N/A |
#7 | $2.5M | 16 | 0% | N/A | N/A |
#8 | $7.4M | 48 | 0% | N/A | N/A |
#9 | $0.2M | 1 | -83% | N/A | N/A |
#10 | $1.7M | 11 | 22% | N/A | N/A |
What Is Cytimmune Sciences?
CytImmune is a global leader in the field of cancer nanomedicine. The company has more than 60 issued and pending patents for its colloidal gold nanotechnology in the United States, European Union, Japan and Canada. We have successfully completed a Phase I clinical trial of CYT-6091 — the first in a series of nanomedicines based on our Aurimune nanomedicine platform. For more information about Aurimune or CytImmune, please visit our website, http://CytImmune.com. To read our opinions on topics relevant to cancer patients and their families, health care professionals, and the research community, visit our blog: http://CytImmune.Blog
keywords:N/A
N/A
Total Funding
9
Number of Employees
$1.4M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Rockville
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.7M | 9 | 0% | N/A |
#2 | $7.5M | 9 | 13% | N/A |
#3 | $0.7M | 9 | 13% | N/A |
#4 | $1.2M | 9 | -82% | N/A |
#5 | $1.1M | 9 | 0% | N/A |